StockData
Syndax Pharmaceuticals Inc logo

Syndax Pharmaceuticals Inc (SNDX) stock

SNDXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 2, 2026Score 3/30
$9.20+0.07 (+0.77%)

Close on Nov 17, 2026Market cap $821.53MP/E –Yield –

Syndax Pharmaceuticals pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Syndax Pharmaceuticals's pe ratio was 72.4× on Jul 29, 2022, against 4.0× a year earlier.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2022Jul 29, 202272.4×+54.7
2019Oct 31, 201917.7×+14.5
2018Dec 31, 20183.2×–

More Syndax Pharmaceuticals figures

See a number that looks wrong?